Related Experiment Video
Updated: Mar 7, 2026

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
White matter lesions and the cholinergic deficit in aging and mild cognitive impairment
Nils Richter1, Anne Michel2, Oezguer A Onur3
1Department of Neurology, University Hospital Cologne, Cologne, Germany; Cognitive Neuroscience, Institute of Neuroscience and Medicine (INM-3), Research Center Jülich, Jülich, Germany; Max Planck Institute for Metabolism Research, Cologne, Germany.
Abstract:
In Alzheimer's disease (AD), white matter lesions (WMLs) are associated with an increased risk of progression from mild cognitive impairment (MCI) to dementia, while memory deficits have, at least in part, been linked to a cholinergic deficit. We investigated the relationship between WML load assessed with the Scheltens scale, cerebral acetylcholinesterase (AChE) activity measured with [11C]N-methyl-4-piperidyl acetate PET, and neuropsychological performance in 17 patients with MCI due to AD and 18 cognitively normal older participants. Only periventricular, not nonperiventricular, WML load negatively correlated with AChE activity in both groups. Memory performance depended on periventricular and total WML load across groups. Crucially, AChE activity predicted memory function better than WML load, gray matter atrophy, or age. The effects of WML load on memory were fully mediated by AChE activity. Data suggest that the contribution of WML to the dysfunction of the cholinergic system in MCI due to AD depends on WML distribution. Pharmacologic studies are warranted to explore whether this influences the response to cholinergic treatment.
Insights
White matter lesions (WMLs) in Alzheimer's disease (AD) impact memory by affecting the cholinergic system. Periventricular WMLs specifically correlate with reduced acetylcholinesterase (AChE) activity, which mediates memory decline in mild cognitive impairment (MCI).
Area of Science:
- Neuroscience
- Neurology
- Radiology
Background:
- Alzheimer's disease (AD) is characterized by white matter lesions (WMLs) and cholinergic deficits, both linked to cognitive decline.
- WMLs, particularly in the periventricular regions, are associated with increased risk of dementia progression in mild cognitive impairment (MCI).
- Memory impairment in AD is partly attributed to a deficit in the cholinergic system.
Purpose of the Study:
- To investigate the relationship between WML load, cerebral acetylcholinesterase (AChE) activity, and memory performance in MCI due to AD.
- To determine if WML distribution influences cholinergic function and memory deficits.
- To compare the predictive power of AChE activity versus WML load for memory function.
Main Methods:
- Assessed WML load using the Scheltens scale in 17 MCI patients and 18 controls.
- Measured cerebral AChE activity via [11C]N-methyl-4-piperidyl acetate positron emission tomography (PET).
- Evaluated neuropsychological performance, focusing on memory function.
Main Results:
- Periventricular WML load, but not nonperiventricular, negatively correlated with AChE activity in both groups.
- Memory performance was associated with both periventricular and total WML load.
- AChE activity was a stronger predictor of memory function than WML load, gray matter atrophy, or age.
- The impact of WML load on memory was fully mediated by AChE activity.
Conclusions:
- The distribution of WMLs influences their contribution to cholinergic system dysfunction in MCI due to AD.
- AChE activity plays a crucial role in mediating the relationship between WMLs and memory deficits.
- Further pharmacologic studies are needed to explore the influence of WML distribution on response to cholinergic treatments.
More Related Videos
12:28Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
12:50Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
Published on: April 14, 2014
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Dementia
The progression of dementia is generally gradual....
Role of Neurotransmitters in Memory
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Alzheimer's Disease: Treatment
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Cognitive Development During Adulthood